Seeking Alpha

Glaucus Research drops the hammer on Teavana (TEA -1.9%) with a claim that an accredited lab in...

Glaucus Research drops the hammer on Teavana (TEA -1.9%) with a claim that an accredited lab in Germany showed the firm's teas contain pesticides above permissible amounts. Shares of Teavana are zigzagging up and down as the veracity of the report is debated, while Teavana-buyer Starbucks snoozes the news.
From other sites
Comments (1)
  • rambler1
    , contributor
    Comments (676) | Send Message
     
    What did these guys get caught short? Why would you pay for tests after a takeover deal was announced?
    20 Nov 2012, 10:09 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs